Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Keeping Calm: Benzodiazepines are the most prescribed anxiolytics and are used by a broad population. However, benzodiazepines can cause unwanted side effects, including sedation, development of tolerance, and withdrawal symptoms after long-term administration. Rupprecht et al. (p. 490 ; published online 18 June) now find that a translocator protein (18-kD) ligand, XBD173, is a fast-acting anxiolytic agent, both in animals and humans, which lacks the unwanted side effects of benzodiazepines and provides a promising target for novel clinically effective anxiolytic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., et al. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.06.005 · Cited by 1,389
Neurosteroids: endogenous regulators of the GABAA receptor
Belelli, D., & Lambert, J. J. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1703 · Cited by 1,159
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives
Rupprecht, R., & Holsboer, F. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01399-5 · Cited by 633
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Patchev, V. K., Shoaib, M., Holsboer, F., & Almeida, O. F. X. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90330-1 · Cited by 306
Self-citation
Research works printed but not linked: 1
- Zwanzger P., Rupprecht R., J. Psychiatry Neurosci. 30, 167 (2005).15944741
Cited by
Items 101–200 of 338
Neurosteroids as neuromodulators in the treatment of anxiety disorders
Longone, P. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00055 · Cited by 55
Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders
Nothdurfter, C., Baghai, T. C., Schüle, C., & Rupprecht, R. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0352-5 · Cited by 65
Self-citationAn update into the medicinal chemistry of translocator protein (TSPO) ligands
Barresi, E., Robello, M., Costa, B., Pozzo, E. D., Baglini, E., Salerno, S., Settimo, F. D., Martini, C., & Taliani, S. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112924 · Cited by 62
Age-related testosterone decline: mechanisms and intervention strategies
Cheng, H., Zhang, X., Li, Y., Cao, D., Luo, C., Zhang, Q., Zhang, S., & Jiao, Y. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01316-5 · Cited by 77
Progesterone modulates neuronal excitability bidirectionally
Kapur, J., & Joshi, S. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135619 · Cited by 60
Taylor, J. M. W., Allen, A.-M., & Graham, A. (2014) · Clinical Science · doi:10.1042/cs20140047 · Cited by 53
Biswas, L., Farhan, F., Reilly, J., Bartholomew, C., & Shu, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123740 · Cited by 60
nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story
Zhu, L., Li, F. Y., & Zhu, D. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01060-7 · Cited by 56
Johnson, P. L., & Shekhar, A. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.016 · Cited by 58
Animal Models of PTSD: The Socially Isolated Mouse and the Biomarker Role of Allopregnanolone
Pinna, G. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00114 · Cited by 50
Ravikumar, B., Crawford, D. K., Dellovade, T., Savinainen, A., Graham, D. L., Lière, P., Oudinet, J., Webb, M., & Hering, H. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.053 · Cited by 55
Global Deletion of TSPO Does Not Affect the Viability and Gene Expression Profile
Wang, H., Zhai, K., Xue, Y., Yang, J., Yang, Q., Fu, Y., Hu, Y., Liu, F., Wang, W., Cui, L., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167307 · Cited by 49
Mages, K., Graßmann, F., Jägle, H., Rupprecht, R., Weber, B. H. F., Hauck, S. M., & Grosche, A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1424-5 · Cited by 52
Self-citationChung, J., Brown, S., Chen, H., Liu, J., Papadopoulos, V., & Zirkin, B. R. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz174 · Cited by 52
Boyd, K. N., Kumar, S., O’Buckley, T. K., Porcu, P., & Morrow, A. L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06509.x · Cited by 54
Malikowska‐Racia, N., & Sałat, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.001 · Cited by 52
Peripheral Biomarkers in DSM-5 Anxiety Disorders: An Updated Overview
Vismara, M., Girone, N., Cirnigliaro, G., Fasciana, F., Vanzetto, S., Ferrara, L., Priori, A., D’Addario, C., Viganò, C., & Dell’Osso, B. (2020) · Brain Sciences · doi:10.3390/brainsci10080564 · Cited by 46
On the Role of the Translocator Protein (18-kDa) TSPO in Steroid Hormone Biosynthesis
Papadopoulos, V. (2014) · Endocrinology · doi:10.1210/en.2013-2033 · Cited by 46
Wang, D., Tian, Z., Guo, Y., Guo, H., Kang, W., Li, S., Den, Y.-T., Li, X., Feng, B., Feng, D., et al. (2015) · Molecular Pain · doi:10.1186/s12990-015-0013-6 · Cited by 52
Targeting Glia Cells: Novel Perspectives for the Treatment of Neuropsychiatric Diseases
Benedetto, B. D., & Rupprecht, R. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311020004 · Cited by 54
Self-citationAllopregnanolone, the Neuromodulator Turned Therapeutic Agent: Thank You, Next?
Pinna, G. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00236 · Cited by 56
Schumacher, M., Guennoun, R., Mattern, C., Oudinet, J., Labombarda, F., Nicola, A. F. D., & Lière, P. (2015) · Steroids · doi:10.1016/j.steroids.2015.08.013 · Cited by 52
Self-citationOwen, D. R. J., Lewis, A. J. M., Reynolds, R., Rupprecht, R., Eser, D., Wilkins, M. R., Bennacef, I., Nutt, D. J., & Parker, C. A. (2011) · Synapse · doi:10.1002/syn.20884 · Cited by 45
Self-citationDesign, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides
Мокров, Г. В., Деева, О. А., Гудашева, Т. А., Ярков, С. А., Яркова, М. А., & Середенин, С. Б. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.049 · Cited by 46
Pharmacological effect of gelsemine on anxiety-like behavior in rat
Meyer, L., Boujedaini, N., Patte‐Mensah, C., & Mensah‐Nyagan, A. G. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.010 · Cited by 49
Kim, T., & Pae, A. N. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1230606 · Cited by 49
Rupprecht, R., Pradhan, A. K., Kufner, M., Brunner, L.-M., Nothdurfter, C., Wein, S., Schwarzbach, J. V., Puig-Bosch, X., Rupprecht, C., & Rammes, G. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01532-3 · Cited by 53
Self-citationDefining the Role of Pharmacology in the Emerging World of Translational Research
Enna, S. J., & Williams, M. J. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57001-3 · Cited by 49
Translocator protein: pharmacology and steroidogenesis
Midzak, A. S., Zirkin, B. R., & Papadopoulos, V. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150061 · Cited by 46
Barron, A. M., Higuchi, M., Hattori, S., Kito, S., Suhara, T., & Ji, B. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02136-5 · Cited by 46
Costa, B., Cavallini, C., Pozzo, E. D., Taliani, S., Settimo, F. D., & Martini, C. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00027 · Cited by 50
Antiseizure Activity of Midazolam in Mice Lacking δ-Subunit Extrasynaptic GABAA Receptors
Reddy, S. D., Younus, I., Clossen, B. L., & Reddy, D. S. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.222075 · Cited by 42
Zwanzger, P., Zavorotnyy, M., Gencheva, E., Diemer, J., Kugel, H., Heindel, W. L., Ruland, T., Ohrmann, P., Arolt, V., Domschke, K., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.61 · Cited by 47
The learned safety paradigm as a mouse model for neuropsychiatric research
Pollak, D. D., Monje, F. J., & Lübec, G. (2010) · Nature Protocols · doi:10.1038/nprot.2010.64 · Cited by 42
Current status and future perspectives: TSPO in steroid neuroendocrinology
Selvaraj, V., & Tu, L. N. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0241 · Cited by 40
TSPO ligand PK11195 improves Alzheimer-related outcomes in aged female 3xTg-AD mice
Christensen, A., & Pike, C. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.06.029 · Cited by 40
Reynolds, A. J., Hanani, R., Hibbs, D. E., Damont, A., Pozzo, E. D., Selleri, S., Dollé, F., Martini, C., & Kassiou, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.135 · Cited by 41
GABA(A) receptor-targeted drug development -New perspectives in perioperative anesthesia
Antkowiak, B., & Rammes, G. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1599356 · Cited by 44
Self-citationLeva, G., Klein, C., Benyounes, J., Hallé, F., Bihel, F. J. ‐., Collongues, N., Seze, J. D., Mensah‐Nyagan, A. G., & Patte‐Mensah, C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.007 · Cited by 47
Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia
Kreisl, W. C., Henter, I. D., & Innis, R. B. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.08.004 · Cited by 38
Corsi, F., Baglini, E., Barresi, E., Salerno, S., Cerri, C., Martini, C., Settimo, F. D., Taliani, S., Gargini, C., & Piano, I. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00582 · Cited by 37
Tomaselli, G., & Vallée, M. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100789 · Cited by 41
Structural Integrity of the A147T Polymorph of Mammalian TSPO
Jaremko, M., Jaremko, Ł., Giller, K., Becker, S., & Zweckstetter, M. (2015) · ChemBioChem · doi:10.1002/cbic.201500217 · Cited by 44
Scott, G., Mahmud, M., Owen, D. R., & Johnson, M. R. (2016) · Seizure · doi:10.1016/j.seizure.2016.10.023 · Cited by 41
Bertoglio, D., Verhaeghe, J. A. J., Santermans, E., Amhaoul, H., Jonckers, E., Wyffels, L., der Linden, A. V., Hens, N., Staelens, S. G., & Dedeurwaerdere, S. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.015 · Cited by 38
Arbo, B. D., Benetti, F., García‐Segura, L. M., & Ribeiro, M. F. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.07.007 · Cited by 45
Pharmacologic Treatment of Panic Disorder
Stein, M. B., Steckler, T., Lightfoot, J., Hay, E., & Goddard, A. W. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_35 · Cited by 38
Mello, N. K., Knudson, I. M., Kelly, M., Fivel, P. A., & Mendelson, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.130 · Cited by 39
Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone
Poisbeau, P., Keller, A. F., Aouad, M., Kamoun, N., Groyer, G., & Schumacher, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00174 · Cited by 38
Self-citationMitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies
Grimm, A., Lejri, I., Hallé, F., Schmitt, M., Götz, J., Bihel, F. J. ‐., & Eckert, A. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12796 · Cited by 39
Stress-related depression: Neuroendocrine, genetic, and therapeutical aspects
Bosch, O. G., Seifritz, E., & Wetter, T. C. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.665477 · Cited by 38
Structure of the mammalian TSPO/PBR protein
Jaremko, M., Jaremko, Ł., Jaipuria, G., Becker, S., & Zweckstetter, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150029 · Cited by 43
Targeting neurosteroidogenesis as therapy for PTSD
Pinna, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00166 · Cited by 36
Involvement of allopregnanolone in the anti-PTSD-like effects of AC-5216
Zhang, L., Qiu, Z.-K., Chen, X.-F., Zhao, N., Chen, H., Xue, R., Zhang, Y., Yang, R., & Li, Y. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115625115 · Cited by 33
Novel investigational therapeutics for panic disorder
Perna, G., Schruers, K. R. J., Alciati, A., & Caldirola, D. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.996286 · Cited by 33
Qiu, Z.-K., He, J.-L., Liu, X., Zhang, G.-H., Zeng, J., Nie, H., Shen, Y., & Chen, J. (2016) · Scientific Reports · doi:10.1038/srep37345 · Cited by 36
Banerji, R., Huynh, C. Q., Figueroa, F., Dinday, M. T., Baraban, S. C., & Patel, M. (2021) · Brain Communications · doi:10.1093/braincomms/fcab004 · Cited by 30
Fukaya, T., Kodo, T., Ishiyama, T., Kakuyama, H., Nishikawa, H., Baba, S., & Masumoto, S. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.023 · Cited by 34
Neurosteroids: A novel promise for the treatment of stroke and post‐stroke complications
Xu, J., Zhou, Y., Yan, C., Wang, X., Lou, J., Luo, Y., Gao, S., Wang, J., Wu, L., Gao, X., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15503 · Cited by 34
Li, X., Liu, A., Yang, L., Zhang, K., Wu, Y., Zhao, M., & Liu, S. (2018) · Molecular Brain · doi:10.1186/s13041-018-0355-x · Cited by 33
Conformational Flexibility in the Transmembrane Protein TSPO
Jaremko, Ł., Jaremko, M., Giller, K., Becker, S., & Zweckstetter, M. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502314 · Cited by 39
Role of neurosteroids in the anticonvulsant activity of midazolam
Dhir, A., & Rogawski, M. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01733.x · Cited by 29
Translocator protein in the rise and fall of central nervous system neurons
Cheung, G., Lin, Y. C., & Papadopoulos, V. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1210205 · Cited by 36
Pike, V. W., Taliani, S., Lohith, T. G., Owen, D. R., Pugliesi, I., Pozzo, E. D., Hong, J. S., Zoghbi, S. S., Gunn, R. N., Parker, C. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101230g · Cited by 33
The translocator protein (18 kDa) and its role in neuropsychiatric disorders
Barichello, T., Simões, L. R., Collodel, A., Giridharan, V. V., Dal‐Pizzol, F., Macêdo, D. S., & Quevedo, J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.010 · Cited by 30
Testosterone recovery therapy targeting dysfunctional Leydig cells
Garza, S., & Papadopoulos, V. (2022) · Andrology · doi:10.1111/andr.13304 · Cited by 31
Altitude is a risk factor for completed suicide in bipolar disorder
Huber, R. S., Coon, H. H., Kim, N., Renshaw, P. F., & Kondo, D. G. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.01.006 · Cited by 30
Progesterone and its metabolites as therapeutic targets in psychiatric disorders
Bristot, G., Ascoli, B. M., Gubert, C., Panizzutti, B., Kapczinski, F. P., & Rosa, A. R. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.897329 · Cited by 36
Zhang, L., Wang, Y., Liu, Y., Xue, R., Zhang, Y., Yang, R., & Li, Y. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.004 · Cited by 29
Gatta, E., Camussi, D., Auta, J., Guidotti, A., & Pandey, S. C. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108299 · Cited by 30
Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System
Schumacher, M., Zhu, X., & Guennoun, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00054-7 · Cited by 31
Self-citationPeripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder
Ye, J., Duan, C., Han, J., Chen, J., Sun, N., Li, Y., Yuan, T., & Peng, D. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01878 · Cited by 34
Dine, J., Ionescu, I. A., Avrabos, C., Yen, Y.-C., Holsboer, F., Landgraf, R., Schmidt, U., & Eder, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120272 · Cited by 28
Self-citationTranslocator protein and new targets for neuroinflammation
Herrera-Rivero, M., Heneka, M. T., & Papadopoulos, V. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0151-x · Cited by 29
Li, X.-M., Meng, J., Li, L., Guo, T., Yang, L.-K., Shi, Q., Li, X., Chen, Y., Yang, Q., & Zhao, J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.025 · Cited by 28
Bruno, A., Barresi, E., Simola, N., Pozzo, E. D., Costa, B., Novellino, E., Settimo, F. D., Martini, C., Taliani, S., & Cosconati, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00300 · Cited by 27
Cappelli, A., Bini, G., Valenti, S., Giuliani, G., Paolino, M., Anzini, M., Vomero, S., Giorgi, G., Giordani, A., Stasi, L. P., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200770f · Cited by 28
ABA, porphyrins and plant TSPO-related protein
Guillaumot, D., Guillon, S., Morsomme, P., & Batoko, H. (2009) · Plant Signaling & Behavior · doi:10.4161/psb.4.11.9796 · Cited by 31
Translocator protein mediates the anxiolytic and antidepressant effects of midazolam
Qiu, Z.-K., Li, M.-S., He, J.-L., Liu, X., Zhang, G.-H., Lai, S., Ma, J.-C., Zeng, J., Li, Y., Wu, H.-W., et al. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.005 · Cited by 26
Яркова, М. А., Мокров, Г. В., Гудашева, Т. А., & Середенин, С. Б. (2016) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-016-1476-0 · Cited by 26
Elkamhawy, A., Park, J.-E., Hassan, A. H. E., Pae, A. N., Lee, J., Park, B.-G., Paik, S., Do, J., Park, J., Park, K. D., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2017.04.015 · Cited by 28
Could a blood test for PTSD and depression be on the horizon?
Aspesi, D., & Pinna, G. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1544894 · Cited by 26
Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets
Taliani, S., Settimo, F. D., Martini, C., Laneri, S., Novellino, E., & Greco, G. (2020) · Molecules · doi:10.3390/molecules25102331 · Cited by 27
Nochi, R., Kato, T., Kaneko, J., Itou, Y., Kuribayashi, H., Fukuda, S., Terazono, Y., Matani, A., Kanatani, S., Nakajima, K., et al. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08128.x · Cited by 32
Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT
Declercq, L., Vandenberghe, R. R., Laere, K. V., Verbruggen, A., & Bormans, G. M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00088 · Cited by 31
TSPO activation modulates the effects of high pressure in a rat ex vivo glaucoma model
Ishikawa, M., Yoshitomi, T., Covey, D. F., Zorumski, C. F., & Izumi, Y. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.09.001 · Cited by 24
Gatta, E., Guidotti, A., Saudagar, V., Grayson, D. R., Aspesi, D., Pandey, S. C., & Pinna, G. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa073 · Cited by 29
Rupprecht, R., Rupprecht, C., Benedetto, B. D., & Rammes, G. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.1961503 · Cited by 27
Self-citationGoddard, A. W. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i1.43 · Cited by 28
Wang, D., Han, J., Li, S., Sun, T., Guo, Y., Kang, W., Tian, Z., Zhao, J., Liu, G., Liu, S., et al. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8425-7 · Cited by 25
Metal complexes targeting the Translocator Protein 18 kDa (TSPO)
Denora, N., Iacobazzi, R. M., Natile, G., & Margiotta, N. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.03.023 · Cited by 25
Emerging drugs for panic disorder
Perna, G., Guerriero, G., & Caldirola, D. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.628313 · Cited by 23
“They showed that XBD173 potentiated GABA-mediated neurotransmission indirectly through the generation of GABAmediated neurosteroids; XBD173 effectively prevented sodium-lactated-induced panic behaviors in panic-prone rats, similarly to alprazolam, but without sedation or reduction in locomotor activity; its anxiolytic…”
BackgroundMethodResultInfluential18F-DPA-714 PET Imaging for Detecting Neuroinflammation in Rats with Chronic Hepatic Encephalopathy
Kong, X., Luo, S., Wu, J. R., Wu, S., Cecco, C. N. D., Schoepf, U. J., Spandorfer, A. J., Wang, C. Y., Tian, Y., Chen, H., et al. (2016) · Theranostics · doi:10.7150/thno.15362 · Cited by 24
Neurosteroids and Oxysterols as Potential Therapeutic Agents for Glaucoma and Alzheimer’s Disease
Ishikawa, M., Yoshitomi, T., Covey, D. F., Zorumski, C. F., & Izumi, Y. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000356 · Cited by 23
The translocator protein (TSPO) is prodromal to mitophagy loss in neurotoxicity
Frison, M., Faccenda, D., Abeti, R., Rigon, M., Strobbe, D., England-Rendon, B. S., Cash, D., Barnes, K., Sadeghian, M., Sajic, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01050-z · Cited by 26
Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina
Farhan, F., Almarhoun, M., Wong, A., Findlay, A. S., Bartholomew, C., Williams, M. T. S., Hurd, T. W., & Shu, X. (2021) · Cells · doi:10.3390/cells10113066 · Cited by 28
Anti-stress effects of ONO-2952, a novel translocator protein 18 kDa antagonist, in rats
Mitsui, K., Niwa, T., Kawahara, Y., Morimoto, N., Ohmoto, K., Kato, M., Yamaura, Y., Yoshimoto, N., Suna, H., & Katsumata, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.011 · Cited by 24
18-kDa translocator protein association complexes in the brain: From structure to function
Costa, B., Pozzo, E. D., & Martini, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114015 · Cited by 27
Leicht, G., Mulert, C., Eser, D., Sämann, P. G., Ertl, M., Laenger, A., Karch, S., Pogarell, O., Meindl, T., Czisch, M., et al. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.004 · Cited by 21
Self-citationShekhar, A., Johnson, P. L., Fitz, S. D., Nakazato, A., Chaki, S., Steckler, T., & Schmidt, M. E. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710001355 · Cited by 21
Metadata
- Authors
- Rupprecht, R., Rammes, G., Eser, D., Baghai, T. C., Schüle, C., Nothdurfter, C., Troxler, T., Gentsch, C., Kalkman, H. O., Chaperon, F., Uzunov, V., McAllister, K. H., Bertaina-Anglade, V., La Rochelle, C. D., Tuerck, D., Floesser, A., Kiese, B., Schumacher, M., Landgraf, R., Holsboer, F., & Kucher, K.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Ludwig-Maximilians-Universität München (DE)
- Novartis Institutes for BioMedical Research (CH)
- Novartis Institute for Biomedical Research (NIBR), Neuroscience, 4056 Basel, Switzerland.
- Biotrial, 3500 Rennes, France.
- F. Hoffmann-La Roche AG (CH)
- Novartis (Switzerland) (CH)
- INSERM UMR 788, and University Paris-Sud 11, 94274 Paris, France.
- Corresponding author
- Rupprecht, Rainer
- Venue
- Science
- Published
- 2009-07-24
- Volume
- 325
- Issue
- 5939
- Pages
- 490-493
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031094958
- Cited by
- 328
- References
- 28
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 17 · 2023: 10 · 2022: 15 · 2021: 13 · 2020: 21 · 2019: 17 · 2018: 18 · 2017: 20 · 2016: 30 · 2015: 32 · 2014: 29 · 2013: 19 · 2012: 20
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- anxiolytics, benzodiazepine alternatives, neurosteroids, panic attacks, sedation, drug tolerance, withdrawal symptoms
- MeSH terms
- Adult, Alprazolam, Animals, Benzodiazepines, Cell Line, Drug Tolerance, gamma-Aminobutyric Acid, Humans, Isoquinolines, Male, Mice, Inbred C57BL, Purines, Receptors, GABA-A, Substance Withdrawal Syndrome, Tetragastrin, Anti-Anxiety Agents, Panic Disorder, Rats, Sprague-Dawley, Receptors, GABA, Neurotransmitter Agents, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.